OTC : SYBX

Synlogic, Inc. — Institutional Ownership

$1.23 USD

$0.03 (2.5%)

Volume
28.64K
Average Volume
67.78K
Market Capitalization
$14.39M
P/E Ratio
-23.25
Dividend Yield
0.00%
Price Target
Year High
$1.87
Year Low
$0.54
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$7.08
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-07-29 Funicular Funds, LP 3.31M 28.30%
2026-07-29 New Enterprise Associates 14, L.P. 2.92M 25.00%
2026-07-29 NEA Partners 14, L.P. 2.92M 25.00%
2026-07-29 NEA 14 GP, LTD 2.92M 25.00%
2026-07-29 Anthony A. Florence, Jr. 2.92M 25.00%
2026-07-29 Mohamad H. Makhzoumi 2.92M 25.00%
2026-07-29 Ma-Weaver Jacob 3.31M 28.30%
2026-07-29 Cable Car Capital, LP 3.31M 28.30%
2026-07-29 Scott D. Sandell 2.92M 25.00%
2026-07-29 Forest Baskett - 0.00%
2026-07-29 Patrick J. Kerins - 0.00%
2026-04-06 Cable Car Capital, LP 3.31M 28.30%
2026-04-06 Funicular Funds, LP 3.31M 28.30%
2026-04-06 Ma-Weaver Jacob 3.31M 28.30%
2026-01-23 Baselake Partners, LP 1.14M 9.70%
2025-11-13 Radoff Bradley Louis 520K 4.40%
2025-02-25 Kryzanowski, John A. 733.41K 6.27%
2024-04-18 Bradley L. Radoff 629.21K 5.40%
2024-02-16 Funicular Funds, LP 3.31M 36.00%
2024-02-14 Armistice Capital, LLC 1.29M 9.99%
2024-02-14 Steven Boyd 1.29M 9.99%
2023-10-04 OrbiMed Advisors LLC 402K 4.70%
2023-10-04 OrbiMed Genesis GP LLC 111.11K 1.30%
2023-10-04 OrbiMed Capital GP VI LLC 290.88K 3.40%
2021-10-01 Peter Kolchinsky 6.67M 9.90%
2021-10-01 RA Capital Healthcare Fund, L.P. 6.67M 9.90%
2021-10-01 RA Capital Management, L.P. 6.67M 9.90%
2021-10-01 Rajeev Shah 6.67M 9.90%
2021-05-10 FMR LLC 7.45M 15.46%
2020-02-14 Aquilo Capital Management, LLC - 0.00%
2020-02-14 Marc Schneidman - 0.00%
2019-06-21 Ginkgo Bioworks, Inc. 8.89M 19.99%
2019-02-14 Aquilo Capital Management, LLC 1.33M 5.20%
2019-02-14 Mr. Marc Schneidman 1.33M 5.20%
2018-05-10 Wellington Management Group LLP 3.56M 14.00%
2018-05-10 Wellington Investment Advisors Holdings LLP 3.56M 14.00%
2018-05-10 Wellington Group Holdings LLP 3.56M 14.00%
2018-05-10 Wellington Management Company LLP 3.44M 13.50%
2018-04-16 Hawkes Bay Master Investors (Cayman) L.P. 1.35M 5.30%
2018-02-13 ( 13-5315170 356.8K 1.67%
2017-09-07 OrbiMed Advisors LLC 1.31M 8.08%
2017-09-07 OrbiMed Capital GP VI LLC 1.31M 8.08%
2017-09-07 Samuel D. Isaly 1.31M 8.08%
2017-09-06 Deerfield Private Design Fund III, L.P. 850.14K 5.22%
2017-09-06 Deerfield Mgmt III, L.P. 850.14K 5.22%
2017-09-06 James E. Flynn 850.14K 5.22%
2017-09-06 Company, L.P. 850.14K 5.22%
2016-02-12 FMR LLC 1.43M 6.86%
2016-02-12 Select Biotechnology Portfolio 1.15M 5.51%
2016-02-12 Abigail P. Johnson 1.43M 6.86%
2015-10-15 EASTERN CAPITAL LIMITED 1.12M 5.40%
2015-10-15 KENNETH B. DART 1.12M 5.40%
2015-10-15 PORTFOLIO SERVICES LTD. 1.12M 5.40%
2015-10-14 NEA 14 GP, LTD 2.97M 14.80%
2015-10-14 Forest Baskett 2.97M 14.80%
2015-10-14 Patrick J. Kerins 2.97M 14.80%
2015-10-14 Scott D. Sandell 2.97M 14.80%
2015-10-14 ( 13-5315170 2.49M 11.00%
2015-10-14 David M. Mott 2.97M 14.80%
2015-10-14 Anthony A. Florence, Jr. 2.97M 14.80%
2015-10-14 Krishna S. Kolluri 2.97M 14.80%
2015-10-14 Peter W. Sonsini 2.97M 14.80%
2015-10-14 Ravi Viswanathan 2.97M 14.80%
2015-10-14 NEA Partners 14, L.P. 2.97M 14.80%
2015-10-14 Peter J. Barris 2.97M 14.80%
2015-10-14 New Enterprise Associates 14, L.P. 2.97M 14.80%
2015-10-14 Harry R. Weller 2.97M 14.80%
2015-10-14 M. James Barrett 2.97M 14.80%
2015-10-08 Sofinnova Venture Partners VIII, L.P. (“SVP VIII”) 2.97M 14.17%
2015-10-08 Dr. Anand Mehra (“Mehra”) 2.97M 14.17%
2015-10-08 Dr. Michael F. Powell (“Powell”) 2.98M 14.18%
2015-10-08 Dr. Srinivas Akkaraju (“Akkaraju”) 2.97M 14.17%
2015-10-08 Cancer Prevention and Research Institute of Texas 2.4M 11.90%
2015-10-08 Sofinnova Management VIII, L.L.C. (“SM VIII”) 2.97M 14.17%
2015-10-08 Dr. James I. Healy (“Healy”) 2.97M 14.17%
SYBX Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $1.12 12.31M $13.79M $14.67M -$ -$878.66K
2024-12-31 $1.40 12.2M $17.07M $18.86M -$ -$1.79M
2023-12-31 $3.85 6.5M $25.03M $23.96M $17.28M $18.35M
2022-12-31 $11.40 4.78M $54.51M $15.86M $20.3M $58.95M
2021-12-31 $36.30 3.69M $133.9M $16.44M $20.59M $138.05M
2020-12-31 $32.40 2.39M $77.41M $32.51M $22.81M $67.7M
2019-12-31 $38.70 2.02M $78.13M $26.18M $25.01M $76.96M
2018-12-31 $105.15 1.59M $167.42M $11.25M $476K $156.64M
2017-12-31 $145.50 448.31K $65.23M $87.02M $891K -$20.91M
2016-12-31 $189.00 2.98M $562.52M $16.43M $1.05M $547.14M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $0.61 12.39M $7.56M $14.1M -$ -$6.54M
2025-12-31 $1.12 12.31M $13.79M $14.67M -$ -$878.66K
2025-09-30 $1.67 12.32M $20.57M $15.59M -$ $4.98M
2025-06-30 $1.27 12.32M $15.65M $17.03M -$ -$1.38M
2025-03-31 $1.24 12.28M $15.23M $17.27M -$ -$2.04M
2024-12-31 $1.40 11.7M $16.38M $18.86M -$ -$2.48M
2024-09-30 $1.49 12.22M $18.21M $19.39M -$ -$1.18M
2024-06-30 $1.49 12.2M $18.18M $19.97M -$ -$1.78M
2024-03-31 $1.76 12.13M $21.35M $24.82M $14.46M $10.99M
2023-12-31 $3.85 8.52M $32.82M $23.96M $17.28M $26.13M
2023-09-30 $2.81 4.7M $13.21M $24.54M $18.2M $6.87M
2023-06-30 $6.45 4.68M $30.19M $46.26M $19.23M $3.16M